文献速递产科母胎医学

日本、荷兰和美国无创产前检测(NIPT)引入与实施的比较:一项整合性综述

Comparing the Introduction and Implementation of Noninvasive Prenatal Testing (NIPT) in Japan, the Netherlands, and the United States: An Integrative Review.
PubMed 文献 · Prenat Diagn · 2025-01-15

该整合性综述纳入184篇白色与灰色文献及非英语来源,分析日本、荷兰、美国引入与实施NIPT的决策考量、实施选择及使用率。识别出影响引入决定的17项考量(分属五个领域)和35项实施选择;2022年估计孕妇NIPT使用率荷兰58%、美国49%、日本9%。

要点

  • 影响NIPT引入决定的17项考量涉及临床、伦理与社会价值观、财务、需求与能力及适用监管五个领域。
  • 美国在决定是否引入NIPT时考虑的因素似乎少于日本或荷兰。
  • 2022年估计孕妇NIPT使用率:荷兰58%、美国49%、日本9%。

核心结论

  • 三国NIPT实施差异部分可由文化价值观、人群特征和医疗体系解释,决策过程中其他更具适应性的方面(如监管)可能对引入NIPT或类似技术的国家有参考价值。

研究设计与样本

  • 整合性文献综述,纳入184篇白色与灰色文献及非英语来源,分析美国、荷兰、日本引入与实施NIPT的过程、利益相关者角色、决策考量、实施选择及NIPT使用率。

主要发现

  • 识别出17项有文献记载的影响是否引入NIPT的考量,分属临床、伦理与社会价值观、财务、需求与能力及适用监管五个领域。
  • 美国在决定是否引入NIPT时考虑的因素似乎少于日本或荷兰。
  • 识别出35项实施选择,三国最终考虑了其中大多数选择但做出不同决定(例如自付费用方面)。
  • 2022年估计孕妇NIPT使用率荷兰58%、美国49%、日本9%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Previous studies suggest that NIPT's implementation differed widely across countries but offer limited insight into what shaped these differences. To address this gap, we conducted an in-depth analysis of how NIPT was incorporated into prenatal care in the US, the Netherlands, and Japan-countries with similar economic status-to identify actionable lessons. We conducted an integrative literature review on the process of introducing and implementing NIPT, stakeholders' roles, documented considerations in the decision to introduce NIPT, implementation choices, and NIPT uptake. We included 184 sources, including white and gray literature and non-English sources. We identified 17 considerations that were documented to have influenced the decision whether to introduce NIPT across five domains: clinical considerations, ethical considerations and societal values, financial considerations, demand and capacity and applicable oversight. Fewer factors seem to have been considered in the US as compared to Japan or the Netherlands. Countries subsequently made choices on how to implement NIPT-we identified 35 such choices. While most of the identified choices were eventually considered by all three countries, they made different decisions (e.g., on out-of-pocket costs). In 2022, the estimated proportion of pregnant persons who used NIPT was 58% in the Netherlands, 49% in the US, and 9% in Japan. While differences in cultural values, population characteristics, and healthcare systems explain some variation, we identified other more adaptable aspects of the decision-making process (e.g., oversight) that may be useful for countries introducing NIPT or similar technologies to consider.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Connor C, Sato T, Bianchi DW, et al. Comparing the Introduction and Implementation of Noninvasive Prenatal Testing (NIPT) in Japan, the Netherlands, and the United States: An Integrative Review. Prenat Diagn. 2025. PMID: 39812652. doi:10.1002/pd.6708

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。